Key Insights

Highlights

Treatment Research

2 treatments under study, led by Clozapine

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05958875Phase 4Recruiting

The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Showing all 1 trials

Research Network

Common Treatments

  • Clozapine1
  • Secondline Antipsychotics Treatment As Usual1

Active Sponsors

  • Dr. Inge Winter1
  • Universität Münster1

Related Conditions

  • Schizophrenia And Related Disorders1

Activity Timeline